China SXT Pharmaceuticals, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
China SXT Pharmaceuticals, Inc. (SXTC) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of $20.76 thousand for the 12-month period ending 2026-03-31, per its 20-F filed 2026-07-01.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2026-07-01
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month as first filed |
|---|---|---|
| 2026-03-31 | $20.76K 20-F · filed 2026-07-01 | |
| 2025-03-31 | $239.94K 20-F · filed 2026-07-01 | |
| 2024-03-31 | $54.48K 20-F · filed 2026-07-01 | |
| 2023-03-31 | $226.00K 20-F · filed 2025-07-31 | |
| 2022-03-31 | $178.29K 20-F · filed 2024-08-13 | |
| 2021-03-31 | $278.44K 20-F · filed 2023-07-31 | |
| 2020-03-31 | $51.88K 20-F/A · filed 2023-05-19 | $1.60M 20-F · filed 2020-07-31 |
| 2019-03-31 | $12.78K 20-F · filed 2021-08-13 | $20.33K 20-F · filed 2019-08-15 |
| 2018-03-31 | $39.03K 20-F · filed 2020-07-31 |